Edwards Comments on US Court Decision

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, commented on a federal jury’s decisions in patent litigation between Edwards and Boston Scientific:

• The jury awarded USD 35 million in damages to Boston Scientific for infringement of U.S. patent number 8,992,608 (the ‘608 patent) for a transcatheter heart valve sealing skirt. Edwards does not expect to pay the jury award since, earlier this year, the U.S. Patent and Trademark office determined that all asserted claims of the ‘608 patent were invalid.
• The jury found that Edwards’ foundational U.S. Spenser Patents for transcatheter heart valves are valid, but not infringed by the Lotus devices. Edwards plans to appeal.

Boston Scientific initiated litigation that now involves multiple patents in multiple venues, and will likely yield court actions over an extended period of time. – Medical Buyer Bureau